ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,188.40
      0.13%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      85.475
      0.43%
      Bitcoin
      62,732.00
      0.21%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      07/01/20241:30AMAlliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:INHCInduction Healthcare Group Plc
      07/01/20241:30AMAlliance NewsAlliance NewsGET READY: Induction Healthcare Group, Porvair at 0700 BSTLSE:PRVPorvair Plc
      07/01/20241:30AMAlliance NewsAlliance NewsAlliance News UK - start of day
      07/01/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
      07/01/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ LSE:0RADOse Immunotherapeutics Sa
      07/01/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’EU:OSEOSE Immunotherapeutics
      07/01/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’LSE:0RADOse Immunotherapeutics Sa
      07/01/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’TG:6OPOSE Immunotherapeutics
      07/01/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ EU:OSEOSE Immunotherapeutics
      07/01/20241:30AMGlobeNewswire Inc.OSE Immunotherapeutics annonce la publication de résultats précliniques d’efficacité de Lusvertikimab dans la Leucémie Aiguë Lymphoblastique dans le journal ‘Blood’ TG:6OPOSE Immunotherapeutics
      07/01/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)LSE:BGHSBoussard & Gavaudan Holding Limited
      07/01/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)EU:BGHLBoussard And Gavaudan Holding Limited
      07/01/20241:30AMGlobeNewswire Inc.Multitude SE: Repurchase of own shares 28.06.2024TG:FRUMultitude SE
      07/01/20241:30AMGlobeNewswire Inc.Kalmar specifies its outlook for 2024
      07/01/20241:30AMGlobeNewswire Inc.Sampo plc’s share buybacks 28 June 2024
      07/01/20241:30AMGlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
      07/01/20241:30AMGlobeNewswire Inc.Multitude SE: Repurchase of own shares 28.06.2024XE:FRUMultitude SE
      07/01/20241:30AMGlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
      07/01/20241:30AMGlobeNewswire Inc.Atlas Luxco S.à r.l., a subsidiary of Atlas Investissement S.A.S., announces public offers to purchase all of the outstanding common shares and SDRs of Millicom International Cellular S.A. for USD 24.00 in cash per Common Share and per SDR
      07/01/20241:30AMPR Newswire (US)XRP Healthcare: Helping to Transform HIV and AIDS Care with Innovative Prescription Savings Solutions
      07/01/20241:30AMPR Newswire (US)XRP Healthcare: Helping to Transform HIV and AIDS Care with Innovative Prescription Savings Solutions
      07/01/20241:18AMBusiness WireBW LPG Limited - Successful Completion of the Redomiciliation to SingaporeNYSE:BWLPBW LPG Limited
      07/01/20241:08AMPR Newswire (Canada)WestJet confirms end to AMFA strike
      07/01/20241:07AMPR Newswire (Canada)KEENON Robotics a fait une présentation intitulée « Where Humans Meet Machines » lors de la Réunion annuelle 2024 des nouveaux champions du Forum économique mondial, à Dalian : Les robots permettent à l'IA d'entrer dans le monde physique
      07/01/20241:05AMBusiness WireHAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award
      07/01/20241:03AMAlliance NewsAlliance NewsTOP NEWS: Japan's manufacturing sector unexpectedly stalls in June
      07/01/20241:01AMAlliance NewsAlliance NewsTOP NEWS: China's manufacturing sector hits highest level since 2021
      07/01/20241:01AMBusiness WireReCerise Therapeutics Inc. Selected for Government Project by MOTIE
      07/01/20241:00AMBusiness WireAndreas & Thomas Strüngmann Award Zeichnet Gründer von HAYA Therapeutics als Erste Preisträger aus
      07/01/20241:00AMBusiness WireAndreas & Thomas Struengmann Award Honors HAYA Therapeutics Co-founders as Inaugural Winners